A SYSTEMATIC REVIEW ON EFFECT OF LACTOBACILLUS SUPPLEMENTATION ON METHOTREXATE EFFICACY IN RHEUMATOID ARTHRITIS
DOI:
https://doi.org/10.22159/ijap.2026v18i1.56515Keywords:
Rheumatoid arthritis, Methotrexate, Lactobacillus, Gut microbiota, DAS28, Cytokines, Probiotics, Systematic review, Meta-analysisAbstract
Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by systemic inflammation and joint destruction. Methotrexate (MTX) remains the cornerstone of therapy but is often limited by variable efficacy and adverse effects. Emerging evidence suggests that gut microbiota modulation, particularly through Lactobacillus supplementation, may enhance the efficacy of MTX via the gut–joint axis.
To systematically review and analyze the impact of Lactobacillus supplementation on methotrexate efficacy in rheumatoid arthritis, focusing on inflammatory biomarkers and disease activity in both human and animal studies.
A comprehensive search was conducted in PubMed, Scopus, Web of Science, and Cochrane CENTRAL up to June 2025 for randomized controlled trials (RCTs) and animal studies comparing MTX + Lactobacillus versus MTX alone. Primary outcomes included TNF-α, IL-6, IL-10, IL-17, CRP, and DAS28. Risk of bias was assessed using Cochrane RoB 2.0 for RCTs and SYRCLE for animal studies. Meta-analysis employed a random-effects model. Human RCTs demonstrated significant reductions in CRP, TNF-α, and IL-6, accompanied by increased IL-10 levels and modest improvement in DAS28 (SMD –0.41). Heterogeneity was attributed to strain, dose, and duration differences. Animal studies provided mechanistic support, showing decreased pro-inflammatory cytokines, enhanced anti-inflammatory markers, and improved histopathology, though findings were not pooled. Gut microbiota-targeted approaches hold promise for improving MTX response, warranting further strain-specific clinical investigations.
References
1. Wang Y, Begum-Haque S, Telesford KM, Ochoa-Reparaz J, Christy MA, Kasper EJ, et al. A commensal bacterial product elicits and modulates migratory capacity of CD39+ regulatory T cells. Mucosal Immunol. 2020;13(1):178–92.
2. Fan H, Tang X, Blanchard T, Lu C, Wang J. Bifidobacterium and Lactobacillus supplementation attenuates methotrexate-induced hepatotoxicity by maintaining gut barrier integrity and modulating gut microbiota. Pharmacol Res. 2021; 166:105407.
3. Sharma S, Saikia UN, Mony U, Arora SK. Symbiotic treatment improves gut barrier function in a rat model of rheumatoid arthritis. Front Immunol. 2021; 12:678102.
4. Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2022;28(2):284–95.
5. Rogier R, Koenders MI, Abdollahi-Roodsaz S. Toll-like receptor mediated modulation of T cell response by commensal intestinal microbiota as a trigger for autoimmune arthritis. J Immunol Res. 2022; 2022:6212903.
6. Al-Khafaji KA, Mohammed-Ali N, Al-Hakeim HK. Evaluation of synbiotic supplementation in rheumatoid arthritis patients on methotrexate: a randomized double-blind placebo-controlled study. Clin Rheumatol. 2023;42(5):1301–10.
7. Singh N, Vyas S, Rathore P, Garg S, Agrawal P, Misra R. Synbiotic combination ameliorates disease activity and oxidative stress in rheumatoid arthritis: a pilot trial. Indian J Rheumatol. 2023;18(2):102–8.
8. Alshammari F, AlShammari T, Alsuhaibani R, Alshammari R, Alsuhaibani L. Modulation of immune markers and oxidative stress in rheumatoid arthritis patients supplemented with Lactobacillus. J Inflamm Res. 2024; 17:111–21.
9. Suez J, Zmora N, Segal E, Elinav E. The pros, cons, and many unknowns of probiotics. Nat Med. 2024;30(1):24–8.
10. Cao Y, Lin P, Jiang L, Lin Q. The interplay between gut microbiota and methotrexate: implications for disease and therapy. Pharmacol Ther. 2025; 250:108357.
11. Pružinská K, Slovák L, Dráfi F, Poništ S, Juránek I, Chrastina M, et al. Enhanced anti-inflammatory effect of the combination of Lactiplantibacillus plantarum LS/07 with methotrexate in experimental arthritis. Molecules. 2022;27(1):189.
12. Baharav E, Mor F, Halabi A, Weinberger A. Lactobacillus GG bacteria ameliorate arthritis in Lewis rats. J Rheumatol. 2004;31(6):1305–9.
13. Jhun J, Min HK, Na HS, Kwon JY, Ryu J, Jung K, et al. Lactobacillus sakei inhibits experimental arthritis by targeting T helper 17 cells and inducing regulatory T cells. J Transl Med. 2020; 18:287.
14. Yang Y, Liu Y, Wang X, Wang Y, Huang F. Protective effects of Lactobacillus acidophilus combination in collagen-induced arthritis rats via gut microbiota modulation. Food Funct. 2025;16(1):214–28.
15. Qin Q, Zhao Z, Liu Y, Zhang Y, Wu S, Li D. Therapeutic potential of Lactiplantibacillus plantarum and its postbiotics in alleviating rheumatoid arthritis. Front Pharmacol. 2024; 15:1185737.
16. Cannarella LAT, dos Santos JC, Oliveira LM, da Silva MV, Braga LC, Sant’Ana MR, et al. Mixture of probiotics reduces inflammatory biomarkers and improves oxidative/nitrosative profile in rheumatoid arthritis patients. Clin Nutr ESPEN. 2021; 46:315–21.
17. Sanchez P, Donet-Mayer C, Martinez-Garcia M, Cuerda C. Efficacy of probiotics in rheumatoid arthritis and spondyloarthritis: a randomized controlled trial. Nutrients. 2022;14(2):354.
18. Pan H, Guo R, Ju Y, Wang Q, Zhu J, Xie Y, et al. A probiotic strain alleviates arthritis via modulation of T cell subsets and gut microbiota. J Ethnopharmacol. 2017; 206:45–56.
19. Ferro M, Găman MA, Bungău S, Behl T. Probiotics and rheumatoid arthritis: an overview of experimental and clinical evidence. Front Pharmacol. 2021; 12:711788.
20. Bungău SC, Behl T, Tit DM, Uivarosan D, Zaha DC, Vesa CM, et al. Targeting probiotics in rheumatoid arthritis: benefits of Lactobacillus rhamnosus GG in rat model. Nutrients. 2021;13(10):3376.
21. delos Angeles Pineda M, Thompson SF, Summers K, de Leon F, Pope J. A randomized double-blinded placebo-controlled pilot study examining the effect of probiotics on disease activity in rheumatoid arthritis. Clin Rheumatol. 2011;30(9):1233–8.
22. Esmaeili F, Heidari M, Rezaei A. Effects of synbiotic supplementation on inflammatory markers in patients with rheumatoid arthritis. Rheumatol Int. 2020;0(3):345–53.
23. Yang Y, Liu Y, Zhou H, Jiang L. Rheumatoid arthritis and the intestinal microbiome: systematic review of probiotic interventions. Front Immunol. 2024; 15:1331486.
24. Yan H, Zhou X, Liu X, Wang D. Gut microbiome as predictor of therapeutic response to methotrexate in rheumatoid arthritis. Front Immunol. 2021; 12:789334.
25. Li Q, Jin J, Jiang L, Zhou M, Zhang Y, Liu Z. Lactiplantibacillus plantarum BX62 alleviates collagen-induced arthritis in rats by restoring gut microbiota. Int J Rheum Dis. 2025;28(1):33–41.
26. Paul AK, Maji C. Role of probiotics in rheumatoid arthritis: therapeutic potential and limitations. Int J Rheum Dis. 2021;24(7):881–9.
27. Chen P, Li J, Liu Z, Sun Y, Ma Y. Lactobacillus reuteri attenuates arthritis severity by modulating gut microbiota and Treg/Th17 balance. J Funct Foods. 2023; 102:105433.
28. Lu Y, Shao T, Sun X, Liu H, Dong Y. Oral administration of Lactobacillus salivarius inhibits collagen-induced arthritis via modulating cytokine levels and gut integrity. Microb Pathog. 2024; 181:106078.
29. Jin Y, Li Y, Lu Y, Zhao H. Lactobacillus casei suppresses inflammation and disease progression in collagen-induced arthritis rats. Probiotics Antimicrob Proteins. 2023;15(3):521–9.
30. Alam MJ, Rahman MM, Hasan MR, Ferdous N, Akter N, et al. Efficacy of multi-strain probiotics in reducing rheumatoid arthritis symptoms in a mouse model. Microorganisms. 2024;12(1):55.
Published
How to Cite
Issue
Section
Copyright (c) 2025 MOHAMMED FAIZAL K., VARSHA K., SUVITHA SRI M., NITHYA SHREE, RAGUNATH S., DEEPALAKSHMI M.
This work is licensed under a Creative Commons Attribution 4.0 International License.
